This finding aligns with previous research that indicated the lack of independence of the preoperative NLR as a prognostic biomarker, particularly in specific subtypes, such as ER+ HER2- early breast cancer, where other clinical prognostic factors may exert a significant influence (44, 45). The gene discussed is ESR1; the disease is breast cancer.